OrthAlign, Inc. Adds Balance Feature to their Lantern(R) Platform, Including Indications for Primary and Revision Knee Arthroplasty
PR98576
ALISO VIEJO, Calif., Nov. 1, 2022 /PRNewswire=KYODO JBN/ --
New feature offers soft-tissue balancing to aid in accurate component
positioning
With its recent addition of the Balance feature to the Lantern platform,
OrthAlign, Inc. is delivering an efficient, easy-to-use, cost-effective
instrument that aids surgeons in soft-tissue balancing during primary and
revision knee replacement procedures.
Photo -
https://mma.prnewswire.com/media/1934354/OrthAlign_Balancing_data_screen.jpg
The first soft-tissue feature to appear as part of the Lantern Knee
application, Balance works in conjunction with the company's Lantern handheld
device, a smart-phone sized instrument that allows for accurate positioning
during partial and total knee arthroplasty.
The initial release spanned over ten states, reaching from Hawaii, to
California, to Florida, and Connecticut, with surgeons using Lantern Balance in
both primary and revision knee procedures to provide accurate component
positioning and ligament balancing. The feature gives surgeons intra-operative
information of the patient's flexion and extension gaps, which is a game
changer for Lantern.
"With technology becoming the standard of care in total joint replacement,
delivering operationally and economically efficient technologies is key.
Lantern Balance is designed to provide personalized alignment without the need
for pre-operative imaging or capital equipment. Now, with Lantern, surgeons can
take advanced surgical technologies to any site of service with ease," says
Eric Timko, Chairman and CEO of OrthAlign.
According to Michael Ast, MD, Chief Medical Innovation Officer of the Hospital
for Special Surgery in New York, soft-tissue balancing is one of the most
critical steps for a successful knee replacement.
Currently, most surgeons balance the soft-tissue using manual qualitative
methods; Balance provides quantitative support to enhance accuracy.
"Determining a patient's balance has historically relied on a surgeon's ability
and skill, which presents difficulties as it relates to reproducibility and
standardization across surgeons. Modern technology, like the Lantern Balance
System, now allows surgeons to more precisely and repeatedly measure the
ligament tension of the knee to balance the knee in a manner that is both
individualized for that patient and reproduceable across surgeons and sites of
service," Ast says.
"It is pertinent now more than ever that patients receive a high level of care
from their surgeons using the most advanced technology available," says
OrthAligns CEO Timko, adding, "Lantern just got brighter with this new,
cutting-edge application."
OrthAlign, Inc., is a privately held U.S.-based medical device company that
provides orthopedic surgeons with advanced precision computer-assisted
technologies designed to deliver healthier and more pain-free lifestyles to
joint replacement patients.
Driven by the belief that everyone deserves exceptional healthcare, we are
committed to making empowering technologies accessible to all.
For more information regarding OrthAlign, please visit www.orthalign.com.
"ORTHALIGN(R), ORTHALIGN PLUS(R), LANTERN(R), KNEEALIGN(R), HIPALIGN(R) and
UNIALIGN(R)" are registered trademarks of OrthAlign, Inc.
SOURCE: OrthAlign
CONTACT: Nic Aldrich, OrthAlign, Inc., Tel: 949-525-9027, naldrich@orthalign.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。